Johanna Arola

Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease

Panu K. Luukkonen, You Zhou, Sanja Sädevirta et al. · Journal of Hepatology · 2016 · 429 citations · Full text

Insulin Resistance, Metabolic Syndrome, Obesity +14

VEGF‐C and VEGF‐D expression in neuroendocrine cells and their receptor, VEGFR‐3, in fenestrated blood vessels in human tissues

Taina A. Partanen, Johanna Arola, Anne Saaristo et al. · The FASEB Journal · 2000 · 353 citations

A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans

Anna Kotronen, Lovisa Johansson, Lina Johansson et al. · Diabetologia · 2009 · 285 citations · Full text

Obesity, Metabolic Syndrome, Hepatology +13

Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease

Partho Sen, S. U. Qadri, Panu K. Luukkonen et al. · Journal of Hepatology · 2021 · 260 citations · Full text

Hepatic Stearoyl-CoA Desaturase (SCD)-1 Activity and Diacylglycerol but Not Ceramide Concentrations Are Increased in the Nonalcoholic Human Fatty Liver

Anna Kotronen, Tuulikki Seppänen‐Laakso, Jukka Westerbacka et al. · Diabetes · 2008 · 243 citations · Full text